Greater clarity and scope for Group critical illness cover from Legal & General Group Protection

by | Sep 5, 2023

Share this article

Legal & General Logo

Legal & General Group Protection has updated its Group critical illness cover (CIC) definitions for cancer, heart attack and dementia to help provide improved clarity to its customers and their insured employees.

In the case of the cancer definition, the changes also allow greater scope in the type of cancer claims that can be made.

The changes made by Legal & General are designed to help keep pace with the latest changes to both diagnostic techniques and treatment.

Legal & General’s changes include:

  • Cancer: Early-stage prostate cancers – the revised wording allows tumours classified as below Gleason score 7 to be included if they have undergone treatment by prostatectomy. 
  • Dementia: Previously, Alzheimer’s and pre-senile dementia appeared as separate definitions. However, the new definition combines Alzheimer’s with all other forms of dementia. This will provide greater clarity to customers around a dementia diagnosis and what is covered
  • Heart attack: The evidence required for a definite diagnosis of heart attack has now been extended to include ‘typical clinical symptoms (for example, characteristic chest pain)’ These changes reflect the latest medical diagnostic techniques used to diagnose this condition and help provide clear expectations of the scope and limitations of what we cover.

James Walker, Head of Product and Proposition, Legal & General Group Protection: “These latest changes aim to help ensure simplicity, reducing any confusion amongst intermediaries, business customers and insured employees alike.

“The cancer wording changes may also result in providing greater certainty, when it comes to claims, helping give reassurance at a vulnerable time whilst boosting confidence in the value of CIC. That said, we’re already seeing this product becoming more important to customers. After seeing group CIC claims almost double in 2021 to £13.2m (from £7.2m in 2020), our latest results announced earlier this year revealed another increase in 2022 to £18m.”

Share this article

Related articles

Trending articles

IFA Talk logo

IFA Talk is our flagship podcast, designed to fit perfectly into your busy life, bringing the latest insight, analysis, news and interviews to you, wherever you are.

IFA Talk Podcast - listen to the latest episode